glp-1 alzheimer's disease drugs show promise in treatment despite trial setback | Zain Khalpey, MD, PhD, FACS posted on the topic Glucagon-like peptide-1 receptor: mechanisms and

Considering that RYGB leads to increased meal-induced activation of NE-expressing NTS neurons in mice [36], it would be interesting to determine the impact of their silencing or ablation on food intake and body weight, with preliminary data suggesting a modest and temporary effect [83]

According to the Cleveland Clinic, GLP-1 receptor agonists like Ozempic can stimulate insulin release, suppress the release of glucagon, slow digestion, and increase how full you feel after eating

One of the most common things patients report: My brain finally feels quiet around food. GLP-1s may help reduce obsessive thoughts about eating, snacking, binge behaviors, and constant cravings

COX7A1 and COX7A2) with the H (heart)-type being expressed in heart and skeletal muscle (COX6A2 and COX7A1) and the L (liver)-type being expressed in non-muscle tissues (COX6A1 and COX7A2)

Some researchers use a small thermometer inside the fridge to monitor actual temperatures, because the dial setting and the actual internal temperature do not always match

Conditional logistic regression estimated adjusted hazard rate ratios (HRs) for GLP-1RA exposure by recency (current 090 days